ClinicalTrials.Veeva

Menu

Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Begins enrollment this month

Conditions

Reproductive Issues

Study type

Observational

Funder types

Other

Identifiers

NCT07388797
2025.875

Details and patient eligibility

About

Hypotheses:

We hypothesize that serum progesterone levels on the day of embryo transfer in HRT-FET cycles are positively associated with clinical pregnancy rates.

Aims:

To evaluate the relationship between serum progesterone levels on embryo transfer day and clinical pregnancy outcomes in frozen-thawed embryo transfer cycles using hormone replacement therapy (HRT).

Primary outcome:

To compare the incidence of clinical pregnancy outcome in those infertility patients undergoing frozen embryo transfer with caterized Progesterone level on the day of embryo transfer

Secondary outcomes:

Biochemical pregnancy rate. Implantation rate. Early pregnancy loss rate. Ectopic pregnancy rate.

Enrollment

370 estimated patients

Sex

Female

Ages

18 to 42 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing FET cycles
  • Infertility patients aged >18 years old and < 42 years old
  • BMI < 30 kg/m2
  • Transfer of at least one good-quality embryo.

Exclusion criteria

  • Severe endocrine disorders (e.g., thyroid dysfunction, premature ovarian failure).
  • Severe uterine factors without treatment (severe endometriosis, extensive or subendometrial fibroid, uterine adherent, endometrial polyps)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems